MOREPEN IN FOCUS

MOREPEN LABORATORIES: CO LAUNCHED FOUR NEW RX PRODUCTS IN APRIL 2025, REINFORCING ITS R&D-DRIVEN GROWTH STRATEGY AND TARGETING ?1,000 CRORE IN FORMULATION BUSINESS OVER FIVE YEARS